Seyed Mohammad Nabavi
Overview
Explore the profile of Seyed Mohammad Nabavi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
264
Citations
9103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sahebnasagh A, Saghafi F, Avan R, Khoshi A, Khataminia M, Safdari M, et al.
Eur J Pharmacol
. 2024 Apr;
972:176571.
PMID: 38614058
No abstract available.
2.
Hassan W, Yekta B, Nabavi S, Banach M, Rezabakhsh A
Curr Probl Cardiol
. 2023 Dec;
49(2):102331.
PMID: 38113696
No abstract available.
3.
Orouji N, Kazemi Asl S, Taghipour Z, Habtemariam S, Nabavi S, Rahimi R
Med Oncol
. 2023 Nov;
40(12):344.
PMID: 37921869
Glucosinolates are naturally occurring β-d-thioglucosides that mainly exist in the Brassicaceae family. The enzyme myrosinase hydrolyzes glucosinolates to form isothiocyanates, which are chemical protectors. Phenethyl isothiocyanate, sulforaphane, and benzyl isothiocyanate...
4.
Amirian R, Badrbani M, Izadi Z, Samadian H, Bahrami G, Sarvari S, et al.
Eur J Med Chem
. 2023 Sep;
260:115765.
PMID: 37659194
Targeted Protein Modification (TPM) is an umbrella term encompassing numerous tools and approaches that use bifunctional agents to induce a desired modification over the POI. The most well-known TPM mechanism...
5.
Keshavarz S, Okoro O, Hamidi M, Derakhshankhah H, Azizi M, Nabavi S, et al.
Coord Chem Rev
. 2023 Aug;
472.
PMID: 37600158
Engineered nanostructures are materials with promising properties, enabled by precise design and fabrication, as well as size-dependent effects. Biomedical applications of nanomaterials in disease-specific prevention, diagnosis, treatment, and recovery monitoring...
6.
Iranshahy M, Hanafi-Bojd M, Aghili S, Iranshahi M, Nabavi S, Saberi S, et al.
RSC Adv
. 2023 Jul;
13(32):22250-22267.
PMID: 37492509
Curcumin-loaded mesoporous silica nanoparticles (MSNs) have shown promise as drug delivery systems to address the limited pharmacokinetic characteristics of curcumin. Functionalization with folic acid and PEGylation enhance anticancer activity, biocompatibility,...
7.
Pirlog B, Ilut S, Pirlog R, Chiroi P, Nutu A, Radutiu D, et al.
Expert Rev Mol Med
. 2023 May;
25:e18.
PMID: 37154101
Background: Glioblastoma (GBM) is the most frequent type of primary brain cancer, having a median survival of only 15 months. The current standard of care includes a combination of surgery,...
8.
Chandramohan K, Balan D, Devi K, Nabavi S, Reshadat S, Khayatkashani M, et al.
Eur J Pharmacol
. 2023 Apr;
949:175699.
PMID: 37011722
Colorectal cancer (CRC) is the third most common cancer and the leading cause of gastrointestinal cancer death. 90% of people diagnosed with colorectal cancer are over the age of 50;...
9.
Sehrawat R, Rathee P, Khatkar S, Akkol E, Khayatkashani M, Nabavi S, et al.
Curr Med Chem
. 2023 Mar;
PMID: 36896902
Background: Dihydrofolate reductase (DHFR) is an indispensable enzyme required for the survival of most prokaryotic and eukaryotic cells as it is involved in the biosynthesis of essential cellular components. DHFR...
10.
Jeandet P, Uddin M, Clement C, Aziz A, Jacquard C, Khan H, et al.
Nat Prod Rep
. 2023 Mar;
40(5):1045-1057.
PMID: 36880302
Though the iconic stilbene resveratrol and its related dimers constitute a top storyline in the field of natural product research, resveratrol oligomers (condensation >2) have been left aside despite their...